Lumanity Acquires Clarion Healthcare from Svoboda Capital Partners

Health Catalyst Acquires Lumeon Limited

August 8, 2024

Healthcare Services

Health Catalyst, Inc. (Nasdaq: HCAT) has completed its acquisition of Lumeon Limited, a digital health company that provides care orchestration software used by provider organizations in the U.S. and United Kingdom. The deal combines Lumeon's Care Orchestration platform with Health Catalyst's analytics and AI capabilities to expand clinical automation, improve care coordination, and support international growth, particularly in the U.K.

Lumanity Acquires Endpoint Outcomes

June 14, 2022

Healthcare Services

Lumanity has acquired Endpoint Outcomes, a specialist in patient-centered clinical outcomes assessments, to strengthen and broaden its health economics and outcomes research (HEOR) capabilities. The acquisition integrates Endpoint's COA expertise with Lumanity's existing HEOR, medical, commercial, and regulatory capabilities to create a comprehensive global HEOR service offering.

Lumanity Acquires Innovative Edge

March 30, 2022

Healthcare Services

Lumanity, a portfolio company backed by Arsenal Capital Partners, has acquired Innovative Edge (IE), a UK-based provider of pharmaceutical product launch and commercialization services. The add-on strengthens Lumanity's end-to-end commercialization and launch capabilities by integrating IE's Launch EcoSystem and Ignite collaborative launch platform into Lumanity's existing life‑sciences services.

Navitus Health Solutions Acquires EpiphanyRx; Lumicera Purchases Quality Drug Clinical Care

July 19, 2021

Healthcare Services

Navitus Health Solutions has acquired EpiphanyRx to broaden its PBM capabilities and mid-market employer reach. Its specialty pharmacy arm, Lumicera Health Services, also acquired Quality Drug Clinical Care in Irvine, California to expand Lumicera's specialty pharmacy footprint and HIV clinical services in the western United States.

Bridges Consumer Healthcare Acquires Clarion Brands from Swander Pace Capital

January 21, 2021

Consumer Products

Bridges Consumer Healthcare LLC, a Charlesbank Capital Partners-backed platform, has acquired Clarion Brands, LLC from Swander Pace Capital. The transaction adds Clarion's portfolio of niche OTC and dietary supplement brands — including Florajen, Lipo-Flavonoid and Certain Dri — to Bridges' ThermaCare platform to drive scale, marketing and distribution expansion.

Lucid Group Acquires HealthCare21

September 12, 2019

Healthcare Services

Lucid Group, backed by private equity partner LDC, has acquired HealthCare21, a 23-year-old healthcare communications consultancy. The add-on expands Lucid's scientific, editorial and digital capabilities and increases its footprint in the North West of the United Kingdom while supporting broader international reach.